Pharmaceutical Research and Manufacturers of America Fnd Inc.

“The head of the regulatory and scientific advocacy department of the pharmaceutical research and manufacturers of america (phrma), a section 501(c)(6) trade association that has a historic and continuing relationship with the foundation, is an ex-officio member of the foundation's board of directors. (up until 2015, the president of phrma was the ex-officio member.) foundation directors must be research and development executives or chief medical officers of companies that are members of phrma, but are elected by the foundation board itself.”

“The foundation form 990 is prepared by bdo usa llp, cpas, and reviewed internally by key financial management and the foundation's president. A copy of the 990 is provided to the board of directors to review prior to filing.”

“All directors, officers and key employees of the foundation must report potential and actual conflicts as they arise. In addition, they are required to sign an annual conflict of interest disclosure statement. When a potential conflict of interest is disclosed to, or otherwise comes to the attention of, the president, the chair of the board or a non-affected director, he or she shall consider all the relevant circumstances and shall determine whether the arrangement is potentially harmful to the best interests of the foundation. If the arrangement is found not to be harmful, then the arrangement may be authorized or approved; otherwise, the director, officer or key employee who is involved or expects to be involved in the arrangement shall be notified that the arrangement is not authorized or approved and, if already in existence, should be terminated. The president shall authorize or approve an arrangement only after consulting with the chair of the board. The chair of the board shall authorize or approve an arrangement only upon a vote of a majority of uninvolved directors.”

“Merit raises and bonuses are determined in accordance with phrma policy based on staff evaluations, and recommendations are forwarded to the president for review. Overall performance of the president of the foundation, including merit raises and bonuses, is also determined in accordance with phrma policy based on staff evaluations by the ex-officio member of the foundation board. This evaluation will be forwarded as a recommendation to the chairman and vice chair of the foundation board for final approval of the president's performance, including compensation/ bonus.”

“The foundation does not make its governing documents or financial statements available to the public.”

“Description of organization mission the phrma foundation works to improve public health by proactively investing in innovative research, education and value-driven health care.”

“Core programs were restructured in 2020. Two new programs were added for Drug Discovery and Drug Delivery. They offer grants and fellowships to young scientists to pursue pharmaceutical research efforts.”

“Several programs will no longer be offered: Pharmacology/toxicology, Informatics, Pharmaceutics, and Clinical and Translational Pharmacology. Programs will be phased out once previously awarded grants are paid in full.”

“Other program services health outcomes - outcomes research spans a broad spectrum of issues from studies evaluating the effectiveness of a particular pharmaceutical intervention to the impact of reimbursement. This program supports young scientists with stipend and research support. Expenses $ 507,551. Grants $ 442,917. Revenue $ 7,184. Pharmaceutics awards support young scientists with stipend and research support. Pharmaceutics is that area of biomedical and pharmaceutical sciences that deals with drug delivery systems, in particular the design and evaluation of contemporary systems, in particular the design and evaluation of contemporary pharmaceutical dosage forms so that they are safe, effective, and reliable. Expenses $ 401,258. Grants $ 351,667. Revenue $ 2,218. Informatics - the goal is to promote the use and development of informatics in an integrative approach towards the understanding of human biological and disease. This program supports young scientists with stipend and research support. Expenses $ 369,404. Grants $ 323,750. Revenue $ 4,559. Clinical pharmacology - the goal is to generate interest in research careers in pharmacology, including clinical pharmacology, among medical and dental students by supporting fellowships. Expenses $ 170,297. Grants $ 149,250. Revenue $ 0. Other programs expenses $ 442,481. Grants $ 91,000. Revenue $ 0.”

“GRANT REFUNDS $31,541”

“The audit oversight process has not changed from the prior year.”